Literature DB >> 31132913

Investigating the toxic effects induced by iron oxide nanoparticles on neuroblastoma cell line: an integrative study combining cytotoxic, genotoxic and proteomic tools.

Dalel Askri1,2,3,4, Valérie Cunin1,2,3, David Béal5, Sylvie Berthier6, Benoit Chovelon3,7, Josiane Arnaud2,3, Walid Rachidi5, Mohsen Sakly4, Salem Amara4, Michel Sève1,2,3, Sylvia G Lehmann1,2,3,8,9.   

Abstract

Nanomaterials have gained much attention for their use and benefit in several fields. Iron Oxide Nanoparticles (IONPs) have been used in Biomedicine as contrast agents for imaging cancer cells. However, several studies reported the potential toxicity of those nanoparticles in different models, especially in cells. Therefore, in our present study, we investigated the effects of IONPs on the SH-SY5Y neuroblastoma cell line. We carried out cytotoxic and genotoxic studies to evaluate the phenotypic effects, and proteomic investigation to evaluate the molecular effects and the mechanisms by which this kind of NPs could induce toxicity. Our results showed that the use of three different sizes of IONPs (14, 22 and 30 nm) induced cell detachment, cell morphological changes, size, and concentration-dependent IONP internalization and cell mortality. IONPs induced slight genotoxic damage assayed by modified comet assay without affecting cell cycle, mitochondrial function, membrane integrity, intracellular calcium level, and without inducing ROS generation. All the studies were performed to compare also the effects of IONPs to the ferric iron by incubating cells with equivalent concentration of FeCl3. In all tests, the NPs exhibited more toxicity than the ferric iron. The proteomic analysis followed by gene ontology and pathway analysis evidenced the effects of IONPs on cytoskeleton, cell apoptosis, and cancer development. Our findings provided more information about IONP effects on human cells and especially on cancer cell line.

Entities:  

Keywords:  Iron oxide nanoparticles neuroblastoma toxicity proteomics

Mesh:

Substances:

Year:  2019        PMID: 31132913     DOI: 10.1080/17435390.2019.1621399

Source DB:  PubMed          Journal:  Nanotoxicology        ISSN: 1743-5390            Impact factor:   5.913


  6 in total

1.  Toxicological Aspects of Iron Oxide Nanoparticles.

Authors:  Natalia Fernández-Bertólez; Carla Costa; Fátima Brandão; João Paulo Teixeira; Eduardo Pásaro; Vanessa Valdiglesias; Blanca Laffon
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

2.  Effects of Iron Oxide Nanoparticles (γ-Fe2O3) on Liver, Lung and Brain Proteomes following Sub-Acute Intranasal Exposure: A New Toxicological Assessment in Rat Model Using iTRAQ-Based Quantitative Proteomics.

Authors:  Dalel Askri; Valérie Cunin; Souhir Ouni; David Béal; Walid Rachidi; Mohsen Sakly; Salem Amara; Sylvia G Lehmann; Michel Sève
Journal:  Int J Mol Sci       Date:  2019-10-19       Impact factor: 5.923

3.  Iron oxide nanoparticle-induced hematopoietic and immunological response in rats.

Authors:  Usha Singh Gaharwar; Sumit Kumar; Paulraj Rajamani
Journal:  RSC Adv       Date:  2020-09-30       Impact factor: 4.036

4.  Proteomics unite traditional toxicological assessment methods to evaluate the toxicity of iron oxide nanoparticles.

Authors:  Junyuan Han; Yongzhang Tian; Minghan Wang; Yajuan Li; Jiye Yin; Wensheng Qu; Changhui Yan; Rigao Ding; Yongbiao Guan; Quanjun Wang
Journal:  Front Pharmacol       Date:  2022-09-12       Impact factor: 5.988

5.  In-Vitro and In-Vivo Tolerance and Therapeutic Investigations of Phyto-Fabricated Iron Oxide Nanoparticles against Selected Pathogens.

Authors:  Amreen Shah; Isfahan Tauseef; Manel Ben Ali; Muhammad Arfat Yameen; Amine Mezni; Amor Hedfi; Syed Kashif Haleem; Sirajul Haq
Journal:  Toxics       Date:  2021-05-08

6.  Quantitative Proteomic Approach Reveals Altered Metabolic Pathways in Response to the Inhibition of Lysine Deacetylases in A549 Cells under Normoxia and Hypoxia.

Authors:  Alfonso Martín-Bernabé; Josep Tarragó-Celada; Valérie Cunin; Sylvie Michelland; Roldán Cortés; Johann Poignant; Cyril Boyault; Walid Rachidi; Sandrine Bourgoin-Voillard; Marta Cascante; Michel Seve
Journal:  Int J Mol Sci       Date:  2021-03-25       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.